Stress Intervention for Chronic Urticaria

University of Mississippi

Status: Completed

Conditions: Chronic Urticaria

Treatments: Behavioral: Stress intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT01111136

2010-0052

Details and patient eligibility

About

Stress and chronic urticaria has been linked. The purpose of the study is to evaluate a patients chronic urticaria and stress levels before and after he/she goes through six sessions designed to help that participant manage his/her stress.

Full description

The purpose of this single-arm, interventional pilot study is to evaluate the effect of psychological stress intervention for patients with chronic urticaria, as many of these patients report heightened levels of stress before and/or after the onset of the urticaria. Participants will meet individually with a University of Mississippi Medical Center psychiatry resident for one hour once a week for six consecutive weeks to be educated on psychological stress intervention techniques. There is no control group for this pilot study. All participants will complete a packet of psychological and dermatological questionnaires before the first session with the psychiatry resident and one week after the final session. All participants will record daily 1) their urticaria symptoms and 2) the type and number of medications taken for his/her chronic hives. If psychological stress intervention proves to be effective, then this therapeutic modality would benefit patients with chronic urticaria, while avoiding addition and/or continuation of medications that may have significant adverse side effects.

Enrollment: 4 patients

Sex: All

Ages: 18 to 64 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Males and females age 18-64 years old who have had hives for longer than 6 weeks.
• Hives persist despite medical therapy.
• Minimum Urticaria Activity Score of 2 (one point from each of the two categories: number of hives and severity of pruritus).

Exclusion criteria

• Urticaria secondary to vasculitis.
• Urticaria as part of an anaphylactic response.
• Use of Omalizumab within 3 months preceding enrollment period.

Trial design

4 participants in 1 patient group

stress intervention

Experimental group

Description:

Stress intervention.

Treatment:

Behavioral: Stress intervention